Head of the Molecular Endocrinology Research Unit, the Center for Stem Cells at the Sheba Medical Center

Prof. Sarah Ferber is one of the most recognized world leaders in cell replacement therapy for diabetes.
 
She studied biochemistry at the Technion under the supervision of Professor Avram Hershko and Professor Aharon Ciechanover, winners of the Nobel Prize in Chemistry in 2004. She completed a post-doctoral fellowship at the Joslin Diabetes Lab at Harvard Medical School.
 
Prof. Ferber's breakthrough discovery suggested that humans carry their own 'stem-cells' throughout adulthood, thus obviating the need for embryonic stem cells for generating an organ in need.
 
Prof. Sarah Ferber received TEVA, LINDNER, RUBIN and WOLFSON awards for this research, in addition to "woman of Achievements" award from the Friends of Sheba in LA-CA-USA.
 
Prof. Ferber is the founder and CSO of Orgenesis Ltd. a development stage company with a novel therapeutic technology that employs a molecular and cellular approach directed at converting the patient’s own liver cells into functional insulin producing cells, as a cell replacement therapy for diabetes.